Depending on the molecular type of BC (ER+/-, HER2+/-, ER+HER2+/non-ER+HER2+, TNBC/non-TNBC), specific genetic alterations and the corresponding number of samples are shown in Figures 10A–H. This evidence concerns the gene ERBB2 and breast cancer.